K7M2 wt cell

SKU:BHC11101159
Bulk Pricing
Overview
Click light‑blue chips for details

K7M2 wt cell is a Osteoblast cell line (Female). It is commonly used as an in vitro model for 1 research. Growth characteristics: Adherent. Supplied as cryopreserved cells with accompanying batch CoA and quality-control documentation.

Species Mouse
Disease model Mouse osteosarcoma
Growth Properties Adherent
Tissue Ascites
Available Options

This cell line is available in the U.S. For non-profit users, please sign and submit the Non-Profit Supply Agreement to orders@biohippo.com before placing an order. For commercial users, please complete the CLEAR Form before ordering, as additional usage fees may apply based on the intended use. For further details, please contact orders@biohippo.com. Products ship after the required agreement is completed; typical delivery is 2–3 business days. Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 10^6 cells for adherent lines or 5 × 10^6 cells for suspension lines (refer to the batch CoA for details).

Options selector
Catalog no. Size
305188 1 cryovial
Field Specification
Species Mouse
The K7M2 wt cell line is derived from a murine osteosarcoma and is frequently utilized in cancer research, particularly for studies investigating the pathogenesis and therapeutic response of osteosarcoma. This cell line is characterized by its high metastatic potential, making it an invaluable model for studying the mechanisms underlying cancer metastasis and for testing anti-metastatic agents. K7M2 wt cells display a typical epithelial morphology and exhibit robust growth in vitro, which facilitates various experimental applications including gene expression studies, drug screening, and genetic manipulation. Researchers leverage the K7M2 wt cell line to explore the molecular and cellular processes involved in osteosarcoma progression. Studies often focus on signaling pathways, such as the Wnt/β-catenin and PI3K/AKT pathways, which are crucial in tumor growth and metastasis. The genetic profile of K7M2 wt cells includes alterations common in osteosarcoma, providing insights into the genetic drivers of this malignancy. Furthermore, this cell line is instrumental in preclinical testing of new therapeutic approaches, including targeted therapies and immunotherapies, offering a platform for translating research findings into potential clinical applications.

SKU:BHC11101159

  • Receptors expressed: Complement(C3), expressed, Fc receptor, IgG, high affinity I(Fcgr1), expressed
  • Tumorigenic: Yes
  • cultureMedium: DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
  • supplements: Supplement the medium with 10% FBS
  • dissociationReagent: Accutase
  • subculturing: Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium.
  • fluidRenewal: 2 to 3 times per week
  • freezeMedium: As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Supplier Ads Slides show

Add dynamic ads with slider